Medical device developed Belluscura has signed its first US distribution agreement for its X-PLO2R™ portable oxygen concentrator portfolio.

Sharing the news on Wednesday (23rd June), Belluscura said the move is part of its wider plan to appoint US distributors to give a country-wide coverage for the X-PLO2R™ portfolio.

Weighing less than 1.5kg, X-PLO2R™ is believed to be the world’s first modular oxygen concentrator to generate more oxygen by weight than any other US Food and Drug Administration cleared product in its class.

The X-PLO2R™ can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week to help improve the quality of life for millions of people worldwide who suffer from chronic lung diseases and respiratory distress.

Commenting on the deal, Robert Rauker, CEO of Belluscura, said, “We are very pleased with the reception the X-PLO2R™ portable oxygen concentrator has received from distributors.”

“We look forward to commercial launch in Q3 of 2021 and we anticipate signing a number of additional distribution agreements in the very near future.”

Located on the East Coast of the US, the contracted distributor is an established nationwide seller of supplemental oxygen equipment.

The company has issued its first purchase order with anticipated delivery of the first X-PLO2R™ oxygen concentrators expected in Q3.

More deals are expected to occur in the second half of 2021 and into 2022.